| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.084 | 0.1 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.1 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.1 |